The larger, accredited teams showed a trend for lower non-relapse mortality but higher relapse incidence; they might have a shorter waiting time, associated with a slightly higher risk profile of their patients ( Frassoni et al. 2000 ).
← all excerpts
Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
1
—
—